APA (7th ed.) Citation

S, C., A, C., V, V., S, F., S, B., S, R., . . . ME, B. (2022). Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. Molecular therapy : the journal of the American Society of Gene Therapy, 30(10), 3333. https://doi.org/10.1016/j.ymthe.2022.09.005

Chicago Style (17th ed.) Citation

S, Crippa, et al. "Mesenchymal Stromal Cells Improve the Transplantation Outcome of CRISPR-Cas9 Gene-edited Human HSPCs." Molecular Therapy : The Journal of the American Society of Gene Therapy 30, no. 10 (2022): 3333. https://doi.org/10.1016/j.ymthe.2022.09.005.

MLA (9th ed.) Citation

S, Crippa, et al. "Mesenchymal Stromal Cells Improve the Transplantation Outcome of CRISPR-Cas9 Gene-edited Human HSPCs." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 30, no. 10, 2022, p. 3333, https://doi.org/10.1016/j.ymthe.2022.09.005.